Inspire Medical Systems, Inc. (INSP)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$63.08+1.51%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · INSP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | 898.7 | 912.0 | 802.8 | 624.8 | 407.9 | 233.4 | 115.4 | 82.1 |
| Total Revenues | — | — | — | — | — | — | — | 82.1 |
| Cost of Revenues | 124.6 | 133.2 | 123.0 | 96.6 | 66.1 | 33.3 | 17.6 | 13.6 |
| Gross Profit | 774.1 | 778.8 | 679.8 | 528.2 | 341.7 | 200.1 | 97.8 | 68.4 |
| Operating Expenses & Income | ||||||||
| Selling, General & Admin | 620.3 | 624.6 | 529.6 | 452.0 | 320.7 | 202.6 | 127.9 | 90.5 |
| R&D Expenses | 99.7 | 103.2 | 114.1 | 116.5 | 68.6 | 37.4 | 26.1 | 12.8 |
| Operating Income | 54.1 | 51.0 | 36.1 | (40.3) | (47.6) | (39.9) | (56.2) | (34.9) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | 0.1 | 0.0 | 0.0 | 1.7 | 2.1 | 2.1 | 2.1 |
| Interest & Investment Income | — | — | — | — | — | 0.1 | 1.1 | 3.8 |
| Net Interest Expenses | — | — | — | — | — | 2.0 | 1.0 | (1.7) |
| Other Non-Operating Income / Expenses | — | 14.7 | 22.4 | 20.4 | 3.3 | (2.1) | (0.9) | 1.7 |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | — | — |
| EBT, Incl. Unusual Items | 69.4 | 65.7 | 58.5 | (19.9) | (44.3) | (42.0) | (57.1) | (33.2) |
| Income Tax Expense | (65.7) | (79.7) | 4.9 | 1.2 | 0.6 | 0.1 | 0.1 | 0.0 |
| Net Income | ||||||||
| Net Income | 135.0 | 145.4 | 53.5 | (21.2) | (44.9) | (42.0) | (57.2) | (33.2) |
| Per Share | ||||||||
| Basic EPS | 4.68 | 4.95 | 1.80 | (0.72) | (1.60) | (1.54) | (2.19) | — |
| Diluted EPS | 4.67 | 4.89 | 1.75 | (0.72) | (1.60) | (1.54) | (2.19) | — |
| Revenue per Share | 31.05 | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 28.8 | 29.4 | 29.8 | 29.3 | 28.1 | 27.3 | 26.1 | — |
| Diluted Weighted Avg Shares | 28.9 | 29.8 | 30.5 | 29.3 | 28.1 | 27.3 | 26.1 | — |
| Supplemental | ||||||||
| EBITDA | — | 65.0 | 42.7 | (37.5) | (45.7) | (38.7) | (55.4) | (34.4) |
| EBIT | 54.1 | 51.0 | 36.1 | (40.3) | (47.6) | (39.9) | (56.2) | (34.9) |
| Effective Tax Rate | -94.6% | — | — | -6.3% | -1.4% | -0.2% | -0.2% | -0.1% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.